Literature DB >> 17617626

Clonal expansion of CD8+ effector T cells in childhood tuberculosis.

Marc Jacobsen1, Anne K Detjen, Henrik Mueller, Andrea Gutschmidt, Sandra Leitner, Ulrich Wahn, Klaus Magdorf, Stefan H E Kaufmann.   

Abstract

The role of CD8(+) T cells in human tuberculosis (TB) remains elusive. We analyzed the T cell repertoire and phenotype in 1) children with active TB (< or =4 years), 2) healthy latently Mycobacterium tuberculosis-infected children, and 3) noninfected age-matched (tuberculin skin test-negative) controls. Ex vivo phenotyping of T cell subpopulations by flow cytometry revealed a significant increase in the proportion of CD8(+)CD45RO(-)CD62L(-)CD28(-)CD27(-) effector T cells (T(EF)) in the peripheral blood of children with active TB (22.1 vs 9.5% in latently M. tuberculosis-infected children, vs 8.5% in tuberculin skin test-negative controls). Analyses of TCR variable beta-chains revealed markedly skewed repertoires in CD8(+) T(EF) and effector memory T cells. Expansions were restricted to single TCR variable beta-chains in individual donors indicating clonal growth. CDR3 spectratyping and DNA sequencing verified clonal expansion as the cause for CD8(+) effector T cell enrichment in individual TB patients. The most prominent enrichment of highly similar T(EF) clones (>70% of CD8(+) T(EF)) was found in two children with active severe TB. Therefore, clonal expansion of CD8(+) T(EF) occurs in childhood TB with potential impact on course and severity of disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17617626     DOI: 10.4049/jimmunol.179.2.1331

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  CD8+ T cells provide an immunologic signature of tuberculosis in young children.

Authors:  Christina Lancioni; Melissa Nyendak; Sarah Kiguli; Sarah Zalwango; Tomi Mori; Harriet Mayanja-Kizza; Stephen Balyejusa; Megan Null; Joy Baseke; Deo Mulindwa; Laura Byrd; Gwendolyn Swarbrick; Christine Scott; Denise F Johnson; LaShaunda Malone; Philipa Mudido-Musoke; W Henry Boom; David M Lewinsohn; Deborah A Lewinsohn
Journal:  Am J Respir Crit Care Med       Date:  2011-10-27       Impact factor: 21.405

2.  Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection.

Authors:  Stephan Schwander; Keertan Dheda
Journal:  Am J Respir Crit Care Med       Date:  2010-11-12       Impact factor: 21.405

Review 3.  Orchestration of pulmonary T cell immunity during Mycobacterium tuberculosis infection: immunity interruptus.

Authors:  Samuel M Behar; Stephen M Carpenter; Matthew G Booty; Daniel L Barber; Pushpa Jayaraman
Journal:  Semin Immunol       Date:  2014-10-11       Impact factor: 11.130

4.  Mycobacterium tuberculosis culture filtrate protein 10-specific effector/memory CD4⁺ and CD8⁺ T cells in tubercular pleural fluid, with biased usage of T cell receptor Vβ chains.

Authors:  Dan Qiao; Li Li; Jian Guo; Suihua Lao; Xianlan Zhang; Jianping Zhang; Changyou Wu
Journal:  Infect Immun       Date:  2011-05-23       Impact factor: 3.441

5.  T regulatory cells and Th1/Th2 cytokines in peripheral blood from tuberculosis patients.

Authors:  X-Y He; L Xiao; H-B Chen; J Hao; J Li; Y-J Wang; K He; Y Gao; B-Y Shi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-03-21       Impact factor: 3.267

6.  TCR repertoire, clonal dominance, and pulmonary trafficking of mycobacterium-specific CD4+ and CD8+ T effector cells in immunity against tuberculosis.

Authors:  George Du; Crystal Y Chen; Yun Shen; Liyou Qiu; Dan Huang; Richard Wang; Zheng W Chen
Journal:  J Immunol       Date:  2010-08-30       Impact factor: 5.422

7.  Bacillus Calmette-Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles.

Authors:  Andreia P Soares; Thomas J Scriba; Sarah Joseph; Ryhor Harbacheuski; Rose Ann Murray; Sebastian J Gelderbloem; Anthony Hawkridge; Gregory D Hussey; Holden Maecker; Gilla Kaplan; Willem A Hanekom
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

8.  Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans.

Authors:  Heiko Bruns; Christoph Meinken; Philipp Schauenberg; Georg Härter; Peter Kern; Robert L Modlin; Christian Antoni; Steffen Stenger
Journal:  J Clin Invest       Date:  2009-04-20       Impact factor: 14.808

9.  Reduced frequency of memory T cells and increased Th17 responses in patients with active tuberculosis.

Authors:  Nancy D Marín; Sara C París; Mauricio Rojas; Luis F García
Journal:  Clin Vaccine Immunol       Date:  2012-08-22

10.  Proposed management of childhood tuberculosis in low-incidence countries.

Authors:  Klaus Magdorf; Anne K Detjen
Journal:  Eur J Pediatr       Date:  2008-05-10       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.